These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 34476500)
1. Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment. Li L; Li L; Hu L; Li T; Xie D; Liu X Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476500 [TBL] [Abstract][Full Text] [Related]
2. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Xu L; Zhang B; Li W Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576437 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. Zhang C; Wang M; Shi C; Shi F; Pei C Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression. Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999 [TBL] [Abstract][Full Text] [Related]
5. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells. Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261 [TBL] [Abstract][Full Text] [Related]
7. miR‑210‑3p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3. Jin Y; Wei J; Xu S; Guan F; Yin L; Zhu H Mol Med Rep; 2019 Jun; 19(6):4946-4954. PubMed ID: 30957179 [TBL] [Abstract][Full Text] [Related]
8. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971 [TBL] [Abstract][Full Text] [Related]
9. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Li N; Yang L; Wang H; Yi T; Jia X; Chen C; Xu P PLoS One; 2015; 10(6):e0128886. PubMed ID: 26043084 [TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving. Wang DY; Li N; Cui YL Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583 [TBL] [Abstract][Full Text] [Related]
11. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT. Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85. Wu D; Lu P; Mi X; Miao J Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155 [TBL] [Abstract][Full Text] [Related]
13. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression. Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of autophagy and endoplasmic reticulum stress in the reversal of platinum resistance of epithelial ovarian cancer cells by naringin. Zhu J; Lin S; Zou X; Chen X; Liu Y; Yang X; Gao J; Zhu H Mol Biol Rep; 2023 Aug; 50(8):6457-6468. PubMed ID: 37326754 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy. Cai Y; An B; Yao D; Zhou H; Zhu J Bioengineered; 2021 Dec; 12(2):10713-10722. PubMed ID: 34747309 [TBL] [Abstract][Full Text] [Related]
16. HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis. Guo J; Dou D; Zhang T; Wang B Cell Transplant; 2020; 29():963689720948447. PubMed ID: 32757663 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783 [TBL] [Abstract][Full Text] [Related]
18. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin. Zhang TM Chemotherapy; 2019; 64(3):119-128. PubMed ID: 31661694 [TBL] [Abstract][Full Text] [Related]
19. L-Tetrahydropalmatine enhances the sensitivity of human ovarian cancer cells to cisplatin via microRNA-93/PTEN/Akt cascade. Gong J; Xing C; Wang LY; Xie SS; Xiong WD J BUON; 2019; 24(2):701-708. PubMed ID: 31128026 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1. Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]